Candlelighting Ceremony | VOICES 2024 NYC Symposium

It has been five years since we have had an in-person event. I am delighted to announce that we will be returning to Washington DC in October!

Emerging Technologies 2024
Wednesday, October 9, 2024 – Washington DC

Location
Pillsbury Winthrop Shaw Pittman LLP
1200 Seventeenth Street NW
Washington, DC 20036-3006

CLICK HERE TO REGISTER $100
Please choose the Academic/Young Professional option to register.

CONFIRMED SPEAKERS

Vincent Caprio, Executive Director, NanoBCA/WIAF

The Honorable Kelly H. Carnes, President & CEO, TechVision21

Justin Burger, Regional Spray Specialist, Spraying Systems Co.

Sam Brauer, PhD, Founder & Principal, Nanotech Plus

Lynn L. Bergeson, Managing Director, Bergeson & Campbell, P.C.

Griffith A. Kundahl, Managing Director, Giralus LLC

Scott Livingston, CEO, Livingston Securities LLC

Joseph Piche, President & CEO, Tetrahedron Inc

—————————————————–
Join us in DC to discuss innovation!

Click here to view full press release
9-11 First Responder Vincent Caprio to be Featured on Close Up Radio

EASTON, CT, UNITED STATES, September 4, 2024 /EINPresswire.com/ — The official number is 2,977. This is how many people passed on from the attack on the World Trade Center on September 11, 2001. Over 7,000 9/11 first responders and 9/11survivors combined have passed away since 9/11 from their 9/11-related injuries. Twenty-three years later, many 9/11 first responders and 9/11 survivors, like Vincent Caprio, Executive Director of NanoBCA, are being diagnosed with illnesses such as cancer and respiratory disease every day. Many people like Vincent were not diagnosed with health issues until 15-20 years after 9/11.

“At present time, the 9/11 World Trade Center Health Program was set up to provide medical monitoring and treatment of WTC-related health conditions. Today, there are 110,000 people enrolled in the program. Each 9/11 first responder and 9/11 survivor’s medical conditions have to be certified by the National Institute for Occupational Safety and Health (NIOSH). Once a person’s medical condition has been certified, then they are able to apply for compensation from the Victim’s Compensation Fund. It is a very complex process, requiring hundreds of hours in order to get certified and receive compensation. While legal guidance is provided, the medical certification process must be done yourself.,” explains Vincent.

These Americans were not policemen, firemen, or EMTs. “They were volunteers, like me, who didn’t have that hierarchy to lean on,” explains Vincent. “On the day of the attack I remained at Ground Zero for 22 hours. I then volunteered for over 400 hours in the months following 9/11. I spent seven years getting into the 9/11 WTC Health Program,” shares Vincent. “And that’s after being decorated by Congress and receiving a certificate from the State of Connecticut stating, ‘Vincent Caprio, in recognition of your heroic dedication to your fellow citizens as a survivor and a 9/11 first responder during the attack on the Twin Towers.’”

The program is a lifesaver for those who are accepted. “Once you’re in, it’s wonderful. I’ve been diagnosed with thyroid cancer, GERD and have chronic respiratory disease. The program pays for my pulmonary doctor and endocrinologist. It covers my medication and inhaler. It’s a godsend. But no one should have to fight for seven years to get certified,” laments Vincent.

As a member of Voices Center for Resilience, Vincent meets with other 9/11 first responders and 9/11 survivors remotely to help them deal with grief and offer hope. As an organization, Voices offers long-term support and resources for mental health care and wellness to victims’ families, responders, survivors, and families of those who died from 9/11-related illnesses “My experience with Voices made me acutely aware that 9/11 first responders and 9/11 survivors, who suffer from PTSD, need mental health therapy regularly. Our government needs to support everyone who responded to the 9/11 disaster to ensure that Americans feel safe responding to overwhelming disasters in the future,” Vincent explains.

Voices Center for Resilience has been sponsoring an annual conference at Ground Zero since 2003. “As every year, this year I will be at the conference along with all the people that manage the Victims Compensation Fund and the 9-11 WTC Health Program. We will be meeting with family members, first responders, and survivors. Our 9/11 community will be there.”

Close Up Radio will feature Vincent Caprio in an interview with Doug Llewelyn on Friday, September 6th at 11 am EST

Listen to the show on BlogTalkRadio

If you have any questions for our guest, please call (347) 996-3389

For more information about Vincent Caprio, please visit the following websites
https://eastoncourier.news/2024/03/03/easton-9-11-responder-honored-with-state-citation/
https://voicescenter.org/
https://nanobca.org/
http://vincentcaprio.org/

Lou Ceparano
Close Up Television & Radio
+1 631-850-3314
email us here
Visit us on social media:
Facebook

AGENDA

2:00-2:05  Opening Remarks
Vincent Caprio
Executive Director, NanoBusiness Commercialization Association (NanoBCA)
vincentcaprio@nynanobusiness.org

Emerging Technologies 2024
Wednesday, October 9, 2024

Location
Pillsbury Winthrop Shaw Pittman LLP
1200 Seventeenth Street NW
Washington, DC 20036-3006

2:05-2:15 Trifluoroacetic Acid in the Environment: Consensus, Gaps, and Next Steps
Society of Environmental Toxicology and Chemistry

Governor Healey signs new law to ban PFAS in firefighter protective gear
MASSPIRG

Some school uniforms found to have high levels of PFAS chemicals, new study says
Fox5 DC

Sam Brauer, PhD
Founder & Principal, Nanotech Plus
2021 NanoBCA Lifetime Achievement Award Recipient
sbrauer@nano-biz.com

————————————————————
2:15-2:30  EHS Update
Carla N. Hutton
Regulatory Analyst, Bergeson & Campbell, P.C.
chutton@lawbc.com

NASEM Will Hold Virtual Town Hall on September 5 as Part of Its Quadrennial Review of the NNI

EPA Proposes SNUR for Graphene Nanoplatelets (Generic)

NSF Biomaterials Program Publishes RFI

EPA Authors Describe Categorization Approach to PFAS to Identify Potential Candidates for Testing and Human Health Assessments

————————————————————
2:30-2:45 Education Update
Marco Curreli, PhD
Executive Director, Omni Nano
marcocurreli@omninano.org

————————————————————
2:45-2:50 Q&A

————————————————————
2:50  Conclusion

AGENDA

2:00-2:10  Opening Remarks
Vincent Caprio
Executive Director, NanoBusiness Commercialization Association (NanoBCA)
vincentcaprio@nynanobusiness.org

United States National Debt $35T

Article Analysis
Sam Brauer, PhD
Founder & Principal, Nanotech Plus
2021 NanoBCA Lifetime Achievement Award Recipient
sbrauer@nano-biz.com

“Everyone is drinking it”: Why this type of ”forever chemical” seems to be everywhere
Scientists are beginning to focus on new types of “forever chemicals” that are far more widespread than earlier realized.
The Washington Post

————————————————————
2:10-2:30  EHS Update
Lynn L. Bergeson
Managing Director, Bergeson & Campbell, P.C.
NanoBCA EHS Chair
lbergeson@lawbc.com

Lynn L Bergeson, Kelly N Garson, “Loper Bright and TSCA: Will the demise of Chevron matter?,” Chemical Watch, July 22, 2024.

Senate Committee Will Hold Hearing on Understanding the Potential Environmental Impacts of 6PPD

EPA Announces Changes to When It Assesses Potential Exposure to Pesticide Spray Drift

BETO Announces Awards to 13 Small Businesses to Develop Innovative Biobased Products and Biomass Processing Technologies

————————————————————
2:30-2:45 Wall Street Update – First half 2024
Scott Livingston
CEO, Livingston Securities
scott@livingstonsecurities.com

————————————————————
2:45-2:50 Q&A

————————————————————
2:50  Conclusion

————————————————————
Our monthly webinars address topics involving the relationship between the science of nanotechnology and Environmental, Health & Safety (EHS), US Legislation, Education, Finance, Manufacturing and Foreign Policy. One of the benefits of NanoBCA membership is access to our previous webinars with America’s leading scientists and engineers.

INDIVIDUAL MEMBERSHIP $250

ACADEMIC/YOUNG PROFESSIONAL MEMBERSHIP $100

The NanoBusiness Commercialization Association (NanoBCA) highly recommends the following event:

Responsible Development, Social Science, and the National Nanotechnology Initiative: A Workshop to Explore Past and Future Intersections
Wednesday, July 24, 2024
9:00am – 5:00pm

Since its inception, the National Nanotechnology Initiative (NNI) has emphasized the importance of responsible development, and social scientists have played important roles in the interdisciplinary research that supports fundamental and applied research in nanotechnology. Following this tradition, the NNI and the National Nanotechnology Coordination Office (NNCO) are convening a workshop to bring together federal experts in nanotechnology with social scientists with expertise on specific tools and frameworks relevant to the responsible development of emerging technologies. The agenda will include a presentation about the recently released “Blueprint for the Use of Social and Behavioral Science to Advance Evidence-Based Policymaking,” introductions to key nanotechnology case studies by federal experts, and flash talks by social scientists. The meeting will promote brainstorming new intersections between social science and nanotechnology R&D with the goals of i) integrating social science into future visions of interdisciplinary research, development, and training, and ii) reinvigorating networks that connect the NNI to the social science community.

———————————————-
Meeting Location:

470 L’Enfant Plaza SW, Suite 8001, Washington, DC 20024. Directions are available here.

Virtual participation is also available, but online attendees will not be able to contribute to small group discussions in the afternoon session. Questions may be collected from online participants to inform the meeting.

———————————————-
Register today to listen in on this important exchange:

CLICK HERE FOR IN-PERSON REGISTRATION

CLICK-HERE FOR VIRTUAL REGISTRATION

———————————————-
AGENDA

9:00am  Welcome and introductions

9:30am  Presentation and Q&A on the “Blueprint for the Use of Social and Behavioral Science to Advance Evidence-Based Policymaking”

9:55am  Presentation and Q&A on the ELSI section of the National Nanotechnology Initiative Environmental, Health, and Safety Research Strategy: 2024 Update

10:15am  Break

10:30am  Social Science Flash Talks (10 mins each)

12:00pm  Lunch

12:45pm  Social Science Flash Talks (10 mins each)

1:30pm  Nanotechnology Case Studies – Introductions by NSET agency representatives

2:15pm  Break

2:30pm  Small-group discussions (rotating among case studies) [Note: this portion of the agenda unavailable to online participants]

4:30pm  Report Out and Discussion

4:45pm  Closing and Next Steps

———————————————-
CONFIRMED PARTICIPANTS

Briñas, Raymond FDA, Office of Food Additive Safety

Brough, Branden NNCO, Director

Chen, Kaiping University of Wisconsin – Madison; Communication Strategies with Diverse Groups

Chen, Hongda USDA/NIFA

Chen, Jermont NIH/NBIB, Division of Discovery Science and Technology

Daemmrich, Arthur Consortium for Science, Policy and Outcomes; Chemical Risk, Testing and Regulatory Cultures

Delborne, Jason NNCO, AAAS Science & Technology Policy Fellow

Evans, Sam Weiss National Security Commission on Emerging Biotechnology; Emerging Technologies and Security

Grieger, Khara North Carolina State University; Risk Analysis, Stakeholder Engagement

Haes, Amanda DOE/Basic Energy Sciences

Hartley, Sarah University of Exeter (UK); Risk Assessment, Responsible Innovation

Merid, Beza Arizona State University; Digital Health and Racial Justice

Nelson, John P. Georgia Institute of Technology; Public Value Mapping, Ethics of Emerging Tech

Palmer, Megan Gingko Bioworks; iGEM Policy and Practice Program

Spadola, Quinn NNCO, Deputy Director

Shelley-Egan, Clare Delft University of Technology; Responsible Development and Nanotechnology

Tomblin, David University of Maryland; Participatory Technology Assessment

Udu-gama, Natasha American Geophysical Union – Thriving Earth Exchange; Community Science

Vietas, Jay NIOSH/Nanotechnology Research Center

Zhernenkov, Misha DOE/Basic Energy Sciences

———————————————-
For further information, contact:

Jason Delborne, AAAS Science and Technology Policy Fellow, NNCO

———————————————-
We hope you will be able to participate!

The NanoBusiness Commercialization Association (NanoBCA) would like to congratulate the recipients of the 2024 Kavli Prize in Nanoscience: Robert S. Langer, Armand Paul Alivisatos, and Chad A. Mirkin. I have had the honor of meeting all three of these distinguished scientists from our Nanotechnology Community.

The 2024 Kavli Prize Laureates in the fields of astrophysics, nanoscience and neuroscience were announced this week by the Kavli Foundation. The Kavli Prize in Nanoscience was awarded to Langer, Alivisatos, and Mirkin “for pioneering work integrating synthetic nanoscale materials with biological function for biomedical applications.” You can watch a 20-minute video of the Kavli Prize announcement here.

The 2024 Kavli Prize in Nanoscience honors Robert S. Langer, Armand Paul Alivisatos and Chad A. Mirkin who each revolutionized the field of nanomedicine by demonstrating how engineering nanoscale materials can advance biomedical research and application. Their discoveries contributed foundationally to the development of therapeutics, vaccines, bioimaging and diagnostics.

“The three scientists, Langer, Alivisatos and Mirkin, have broadened the scientific field of nanoscience, building from fundamental research. By scientific curiosity they have become inventors for the future of nanoscience and biomedicine,” stated Bodil Holst, Chair of the Nanoscience Committee.

Robert S. Langer was the first to develop nano-engineered materials that enabled the controlled release, or regular flow, of drug molecules. This capability has had an immense impact for the treatment of a range of diseases, such as aggressive brain cancer, prostate cancer and schizophrenia. His work also showed that tiny particles, containing protein antigens, can be used in vaccination, and was instrumental in the development of the delivery of mRNA vaccines.

Armand Paul Alivisatos demonstrated that semiconductor nanocrystals, or quantum dots (nanoparticles that possess bright, size-dependent light-emitting properties), can be used as multicolor probes in bioimaging. Essential to this achievement was the synthesis of biocompatible nanocrystals. Semiconductor nanocrystals became the basis for the widely used research and diagnostic tools such as live cell tracking, labelling and in vivo imaging.

Chad A. Mirkin engineered spherical nucleic acids (SNA) using a gold nanoparticle as the core, and a cloud of radially distributed DNA or RNA strands as the shell. He was then able to show how SNAs can be combined to create larger structures and how they can be used in biodiagnostics. His discovery led to the development of fast, automated point-of-care medical diagnostic systems.

Once again, we would like to congratulate Robert S. Langer, Armand Paul Alivisatos, and Chad A. Mirkin for their enormous contributions to our Nanotechnology Community.